• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者残疾程度对肺康复反应的影响。

Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

机构信息

Department of Rehabilitation Medicine, Nagasaki University Hospital, Nagasaki, Japan.

出版信息

Respirology. 2011 Nov;16(8):1196-202. doi: 10.1111/j.1440-1843.2011.02029.x.

DOI:10.1111/j.1440-1843.2011.02029.x
PMID:21810145
Abstract

BACKGROUND AND OBJECTIVE

It is unclear whether the severity of functional limitation resulting from IPF affects the response to pulmonary rehabilitation. The aim of this study was to compare the outcomes of rehabilitation in patients with IPF, who were grouped according to the Medical Research Council (MRC) dyspnoea scale.

METHODS

Sixty-five subjects (46, 71% men) with stable IPF were enrolled in an 8-week pulmonary rehabilitation programme. Subjects with MRC dyspnoea grades 2, 3 and 4 undertook a supervised outpatient programme, whereas subjects with MRC dyspnoea grade 5 participated in an unsupervised, home-based programme, with review every 2 weeks. The outcome measures included functional exercise capacity (6MWD), health status (Medical Outcomes Study Short Form 36 (SF-36)) and dyspnoea (transition dyspnoea index), which were measured at baseline and immediately after the programme. Hospitalizations for respiratory exacerbations were compared for the 12 months preceding and following the programme.

RESULTS

The number of subjects with MRC dyspnoea grades 2, 3, 4 and 5 were 16 (25%), 17 (26%), 17 (26%) and 15 (23%), respectively. There were differences between these groups in the magnitude of change in 6MWD, SF-36 and transition dyspnoea index (all P < 0.05). Specifically, subjects with MRC dyspnoea grade 2 or 3 demonstrated clinically and statistically significant improvements in 6MWD and SF-36 following rehabilitation (all P < 0.05). In contrast, for all measures, subjects with MRC dyspnoea grade 4 or 5 showed little or no improvement, or deteriorated following rehabilitation. Hospitalizations were reduced following rehabilitation only in subjects with MRC dyspnoea grade 2, 3 or 4 (P<0.05).

CONCLUSIONS

The response to pulmonary rehabilitation in subjects with IPF varies depending on the MRC grade of dyspnoea, with little benefit being observed in subjects with severe functional limitation.

摘要

背景与目的

特发性肺纤维化(IPF)所致功能受限严重程度对肺康复反应的影响尚不清楚。本研究旨在比较 IPF 患者根据英国医学研究理事会(MRC)呼吸困难量表分组后的康复结局。

方法

纳入 65 例(46 例,71%为男性)稳定期 IPF 患者,参加 8 周肺康复计划。MRC 呼吸困难分级 2、3 和 4 级患者接受门诊监督康复,MRC 呼吸困难分级 5 级患者接受非监督家庭康复,每 2 周复查。主要终点是功能运动能力(6 分钟步行距离,6MWD)、健康状况(健康调查简表 36 项,SF-36)和呼吸困难(过渡呼吸困难指数),于基线和康复计划结束后即刻测量。比较康复前后 12 个月内因呼吸恶化住院的情况。

结果

MRC 呼吸困难分级 2、3、4 和 5 级患者分别有 16 例(25%)、17 例(26%)、17 例(26%)和 15 例(23%)。6MWD、SF-36 和过渡呼吸困难指数的变化程度在这些组之间存在差异(均 P<0.05)。具体而言,MRC 呼吸困难分级 2 或 3 级患者康复后 6MWD 和 SF-36 均有临床和统计学意义上的改善(均 P<0.05)。相比之下,MRC 呼吸困难分级 4 或 5 级患者的所有指标改善甚微或无改善,甚至恶化。仅 MRC 呼吸困难分级 2、3 或 4 级患者的住院率在康复后降低(P<0.05)。

结论

IPF 患者对肺康复的反应因 MRC 呼吸困难分级而异,严重功能受限患者获益甚微。

相似文献

1
Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者残疾程度对肺康复反应的影响。
Respirology. 2011 Nov;16(8):1196-202. doi: 10.1111/j.1440-1843.2011.02029.x.
2
Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council dyspnea grade.根据医学研究委员会呼吸困难分级对特发性肺纤维化患者的活动受限情况进行评估。
Arch Phys Med Rehabil. 2014 May;95(5):950-5. doi: 10.1016/j.apmr.2014.01.016. Epub 2014 Feb 3.
3
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.特发性肺纤维化患者行肺康复治疗的获益预测因素。
Respir Med. 2012 Mar;106(3):429-35. doi: 10.1016/j.rmed.2011.11.014. Epub 2011 Dec 17.
4
Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade.肺康复对 COPD 是有效的,与 MRC 呼吸困难分级无关。
Respir Med. 2009 Jul;103(7):1070-5. doi: 10.1016/j.rmed.2009.01.009. Epub 2009 Feb 13.
5
Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.特发性肺纤维化和慢性阻塞性肺疾病对肺康复反应的差异。
Respiration. 2011;81(3):196-205. doi: 10.1159/000315475. Epub 2010 May 27.
6
Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis.特发性肺纤维化的居家肺康复治疗
Rev Mal Respir. 2011 Sep;28(7):e52-7. doi: 10.1016/j.rmr.2011.06.006. Epub 2011 Jul 30.
7
Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.接受肺康复计划的慢性阻塞性肺疾病(COPD)患者肺功能、症状、健康相关生活质量和运动耐力的七年病程
Respir Med. 2007 Sep;101(9):1961-70. doi: 10.1016/j.rmed.2007.04.007. Epub 2007 May 24.
8
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.肺康复对特发性肺纤维化患者的影响。
Respirology. 2008 May;13(3):394-9. doi: 10.1111/j.1440-1843.2007.01205.x.
9
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.间质性肺疾病患者进行运动训练后运动能力和症状的短期改善
Thorax. 2008 Jun;63(6):549-54. doi: 10.1136/thx.2007.088070. Epub 2008 Feb 1.
10
Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade.根据医学研究委员会(MRC)呼吸困难分级分层后进入康复治疗的慢性阻塞性肺疾病(COPD)患者的肺外特征
Respir Med. 2007 Dec;101(12):2454-63. doi: 10.1016/j.rmed.2007.07.003. Epub 2007 Aug 31.

引用本文的文献

1
Effect of Chest Physiotherapy on Quality of Life, Exercise Capacity and Pulmonary Function in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.胸部物理治疗对特发性肺纤维化患者生活质量、运动能力和肺功能的影响:一项系统评价和荟萃分析
Healthcare (Basel). 2023 Nov 8;11(22):2925. doi: 10.3390/healthcare11222925.
2
IPF Respiratory Symptoms Management - Current Evidence.特发性肺纤维化的呼吸症状管理——当前证据
Front Med (Lausanne). 2022 Jul 28;9:917973. doi: 10.3389/fmed.2022.917973. eCollection 2022.
3
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis.
尼达尼布治疗特发性肺纤维化的肺康复长期效果方案
ERJ Open Res. 2021 Aug 23;7(3). doi: 10.1183/23120541.00321-2021. eCollection 2021 Jul.
4
Early Intervention of Pulmonary Rehabilitation for Fibrotic Interstitial Lung Disease Is a Favorable Factor for Short-Term Improvement in Health-Related Quality of Life.肺康复早期干预对纤维化间质性肺疾病是健康相关生活质量短期改善的有利因素。
J Clin Med. 2021 Jul 16;10(14):3153. doi: 10.3390/jcm10143153.
5
Respiratory Impairment, Limited Activity, and Pulmonary Rehabilitation in Patients with Interstitial Lung Disease.间质性肺疾病患者的呼吸功能损害、活动受限与肺康复
Phys Ther Res. 2021 Apr 1;24(1):9-16. doi: 10.1298/ptr.R0012. eCollection 2021.
6
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis.改善间质性肺疾病症状控制、功能运动能力和生活质量的药物和非药物干预措施:证据综合分析
ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00107-2020. eCollection 2021 Jan.
7
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化患者的健康相关生活质量:系统评价和荟萃分析。
Eur Respir Rev. 2020 Nov 5;29(158). doi: 10.1183/16000617.0154-2020. Print 2020 Dec 31.
8
Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis.有氧运动和呼吸练习可改善特发性肺纤维化患者的呼吸困难、运动能力和生活质量:系统评价与荟萃分析。
J Thorac Dis. 2020 Mar;12(3):1041-1055. doi: 10.21037/jtd.2019.12.27.
9
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.间质性肺疾病慢性呼吸衰竭的管理:概述与临床见解。
Int J Med Sci. 2019 Jun 10;16(7):967-980. doi: 10.7150/ijms.32752. eCollection 2019.
10
8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.8 英尺起立行走测试与特发性肺纤维化患者的住院和死亡相关:一项前瞻性初步研究。
Lung. 2019 Feb;197(1):81-88. doi: 10.1007/s00408-018-0189-4. Epub 2019 Jan 2.